SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Dino's Bar & Grill

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Goose94 who wrote (85710)5/29/2020 2:09:15 PM
From: Goose94Read Replies (2) of 202435
 
Protech Home Medical (PTQ-V) top pick from Robert McWhirter on BNN.ca Market Call Friday May 29th @ 1200ET

Protech provides in-home monitoring and respiratory disease management in the U.S. On May 19, reported a 13.6 per cent YOY increase in sales per share and 13.7 per cent YOY cash flow growth. Free cash flow was $11.4 million on a trailing 12-month (TTM) basis, giving a significant 18 per cent (A+) free cash flow yield.While it has $29 million of debt, the net debt to EBITDA is 1.34 times (B-). September 2021 earnings of $0.06 are forecast to grow 133 per cent in 2022 giving P/E multiples of 17.7 times and 7.6 times respectively. Protech’s TTM return on invested capital is an attractive 31.9 per cent (A+) The consensus $2.50 target by five analysts implies 97 per cent upside potential.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext